Skip to main content
$243.73 -4.61 (-1.86%) At close · Jul 28
Market Cap
$175.31B
Shares
705.91M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$248.34 Open$251.14 Day$248.34–251.78 52W$156.38–251.78 Avg vol 30d3.3M Short int19.1M · 2.7% float · 6.7d Short vol47% Last earningsJul 28, 2026 DataJan 2020–Jul 2026 Filing10-Q · Jul 28

Up next

Next earnings call
Oct 27, 2026 Est · unconfirmed · in 13 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Jul 28, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Weak Quant / Vol Very Low
      Market backdrop VIX 18.2 · elevated Equity put/call 0.71
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +23%
      above
      Price vs 50-day avg +12%
      above
      RSI (14) 72
      overbought
      MACD trend Positive
      52-week position 96%
      near high
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Strong
      1-month return +11%
      trailing
      6-month return +32%
      trailing
      YTD return +34%
      this year
      Relative strength +26%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $221 › 200d $202 — 50d above 200d
      Institutional flow Distributing
      503 of 1,491 funds reported for Jun 30 · net -533.4K sh shares · +64 new
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      2.70% of float · ▼ -1.6% MoM · 6.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      1,491 holders — near 3-yr high, broad support
      Squeeze score 72
      high risk · 0–100
      Fundamentals
      Weak
      Revenue growth +36%
      Y/Y
      EPS growth −11%
      Y/Y
      Valuation P/E 123.6
      rich
      Buyback $499.3M
      remaining
      Balance sheet $14.2B
      net debt
      Quant / Vol
      risk profile
      Very Low
      Volatility 22%
      annualized · 1-yr
      Max drawdown −13%
      past year
      ATR 2.1%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 0 of last 4
      Latest guidance · from the 8-K filed Jul 27, 2026
      full year 2026
      Net income attributable to common stockholders Initiated $3.11 – $3.19
      prior FY $1.39 midpoint +126.6% Y/Y
      Normalized FFO attributable to common stockholders Raised $6.36 – $6.44
      Same Store NOI growth (blended) Initiated 13.75% – 16%
      Seniors Housing Operating SSNOI growth Initiated 18.5% – 21.5%
      Outpatient Medical SSNOI growth Initiated 2% – 3%
      Seniors Housing Triple-net SSNOI growth Initiated 3.5% – 4.5%
      Long-Term/Post-Acute Care SSNOI growth Initiated 2% – 3%
      General and administrative expenses Raised $265M – $270M
      Stock-based compensation expense Maintained $60M
      next twelve months
      Pro rata disposition proceeds $1.1B
      Guided vs delivered · last 4 settled
      Net income attributable to common stockholders full year 2025
      guided $1.86 – $1.94
      $1.39 Miss −26.8%
      Net income attributable to common stockholders 2024
      guided $1.75 – $1.81
      $1.57 Miss −11.8%
      Net income attributable to common stockholders full year 2023
      guided $0.91 – $0.95
      $0.66 Miss −29.0%
      Net income attributable to common stockholders ("NICS") 2Q2022
      guided $0.22 – $0.25
      $0.20 Miss −14.9%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 2 · 4
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +23% Bullish
      Price vs 50-day avg
      +12% Bullish
      RSI (14)
      72 Bearish
      MACD trend
      Positive Bullish
      52-week position
      96% Bullish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $221 › 200d $202 — 50d above 200d
      Institutional flow Distributing
      503 of 1,491 funds reported for Jun 30 · net -533.4K sh shares · +64 new
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      2.70% of float · ▼ -1.6% MoM · 6.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      1,491 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      52-wk low $156 Now $248 · 96% 52-wk high $252
      vs 200-day avg +23% vs 50-day avg +12%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      Net debt to consolidated enterprise value non-GAAP 8.9% as of June 30, 2026
      OM Portfolio pro rata proceeds from sale year-to-date $1.9B year-to-date 2026
      Pro rata gross investments closed or under contract $15.5B year-to-date 2026
      Pro rata gross investments closed or under contract subsequent to quarter end $6.1B subsequent to quarter end
      Pro rata gross investments completed $9.4B six months ended June 30, 2026
      Pro rata gross investments completed (including development funding) $6.3B second quarter
      SHO portfolio SSNOI growth non-GAAP 20.5% second quarter
      Total capital sourced $4B second quarter
      Total portfolio year-over-year same store NOI growth non-GAAP 15.5% second quarter
      normalized funds from operations attributable to common stockholders (per diluted share) non-GAAP $1.47 first quarter
      pro rata gross investments 3.3B first quarter
      SHO portfolio SSNOI 22.1% first quarter
      Annual normalized FFO attributable to common stockholders per diluted share non-GAAP $5.29 full year 2025
      Barchester acquisition price 5.2B fourth quarter
      Barchester communities managed in RIDEA structure 111 fourth quarter
      Barchester communities subject to long-term triple-net lease 150 fourth quarter
      Barchester ongoing developments 21 fourth quarter
      HC-One acquisition equity purchase price 1.2B fourth quarter
      HC-One existing loan repaid 660M fourth quarter
      OM Portfolio properties sold 241 the fourth quarter
      OM Portfolio size 18M as of December 31, 2025
      OM Portfolio total transaction value $7.2B as of December 31, 2025
      Pro rata dispositions and loan payoffs completed $7.5B the fourth quarter
      Pro rata gross investments closed or under contract subsequent to year end $5.7B subsequent to year end
      Pro rata net investments completed $11B full year 2025
      Reported quarterly normalized funds from operations attributable to common stockholders of $1.45 non-GAAP $1.45 fourth quarter
      Seniors Housing Fund I total equity commitments $2.5B the fourth quarter
      Seniors Housing Operating portfolio properties 1,659 4Q25
      Seniors Housing Operating portfolio units 160,218 4Q25
      Seniors Housing Operating Same Store properties 875 4Q25
      SHO portfolio same store NOI growth 20.4% the fourth quarter
      SHO SSNOI margin expansion 270 the fourth quarter

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      REIT - Healthcare Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      WELL
      Welltower Inc.
      this stock
      $175.31B +34.3% +35.6% 123.6 2.7%
      VTR
      Ventas, Inc.
      $47.71B +27.6% +18.5% 178.4 5.1%
      DOC
      Healthpeak Properties, Inc.
      $15.53B +42.6% +4.5% 70.4 3.5%
      OHI
      Omega Healthcare Investors Inc
      $15.31B +18.2% +13.2% 24.7 4.5%
      AHR
      American Healthcare REIT, Inc.
      $11.12B +23.3% +9.1% 97.8 11.4%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      1,528
      % held
      89.8%
      Reported
      503 of 1,491
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      952
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      19.1M
      Days to cover
      6.7d
      Change
      -307.2K sh
      View
      Short Volume
      Short vol %
      47%
      As of
      Jul 28, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      8
      Value
      $1.8K
      As of
      Jun 30, 2026
      View
      Off-Exchange
      Off-exchange %
      47.2%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Buy
      Member
      Alan Armstrong
      Amount
      $1.0K–$15.0K
      Traded
      Mar 30, 2026
      View
      Financials
      Financials
      Revenue (FY)
      $10.8B
      Net income (FY)
      $217.6M
      EPS diluted
      $1.39
      View
      Buybacks
      Authorized
      $3.0B
      Remaining
      $499.3M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jul 28, 2026
      This year
      13
      View
      Proposed Sales
      Value
      $605.4K
      Shares
      4.0K
      Filed
      Apr 30, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 28, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      WELL +2.1% +11.0% +32.3% +9.4% +34.3%
      SPY -0.4% +1.4% +6.3% -1.0% +8.4%
      vs SPY +2.5% +9.6% +26.0% +10.5% +25.9%

      Capital returns

      Latest dividend
      $0.74 / share · ex May 13, 2026
      Raised 10.4%
      Paid (TTM)
      $2.96 / share · 4 payouts
      Dividend yield (TTM, derived)
      1.19%
      Buyback program · as of Mar 31, 2021
      Authorized
      $3.00B
      Spent (derived)
      $2.50B
      Remaining
      $499.34M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 766704 CUSIP 95040Q104 13F (30d) 517 filings 477 filers Visit website Investor relations